Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuprofen + Caffeine FDC for Postoperative Dental Pain
NCT01929031Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Aug 2013
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Ibuprofen + caffeine in odontalgia (6 arms), sponsored by Boehringer Ingelheim. Primary endpoint: Time-weighted Sum of Pain Relief and Pain Intensity Difference From 0 to 8 Hours. Started Aug 2013; status: completed.
02
Drugs
Ibuprofen + caffeine
03
Conditions
odontalgia
Beyond the preview
Go deeper on NCT01929031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01929031.